Metabolite | p value | Mean [95% CI] | |
---|---|---|---|
Control | AD | ||
Neutral vs acidic synthesis pathway | |||
CA | 0.0321 | 27.4 [20.8–36.2] | 19.3 [13.6–27.4] |
CDCA | 0.978 | 38.7 [29.2–51.5] | 46.7 [32.6–66.9] |
CA/CDCA | 0.0008 | 0.707 [0.571–0.876] | 0.363 [0.271–0.487] |
GCDCA/GDCA | 0.5 | 2.08 [1.66–2.61] | 1.97 [1.51–2.57] |
TDCA/TLCA | 0.0114 | 1.33 [1.1–1.62] | 1.81 [1.49–2.21] |
Conjugation, neutral synthesis pathway | |||
GDCA/DCA | 0.0031 | 0.719 [0.604–0.856] | 1.05 [0.836–1.33] |
TDCA/DCA | 0.1 | 0.0605 [0.0467–0.0783] | 0.0777 [0.0556–0.109] |
GCA/CA | 0.0104 | 2.52 [1.86–3.39] | 4.13 [2.84–6.01] |
TCA/CA | 0.076 | 0.506 [0.358–0.716] | 0.711 [0.434–1.16] |
Conjugation, acidic synthesis pathway | |||
GUDCA/UDCA | 0.7 | 0.546 [0.341–0.876] | 0.515 [0.334–0.793] |
TUDCA/UDCA | 0.746 | 2.83 [1.93–4.17] | 2.04 [1.33–3.13] |
GCDCA/CDCA | 0.491 | 8.15 [6.21–10.7] | 8.36 [5.68–12.3] |
TCDCA/CDCA | 0.644 | 0.734 [0.53–1.01] | 0.687 [0.433–1.09] |
TLCA/LCA | 0.961 | 0.282 [0.2–0.396] | 0.252 [0.182–0.347] |
GLCA/LCA | 0.721 | 0.711 [0.53–0.955] | 0.749 [0.552–1.02] |
Conversion of primary to secondary. Gut metagenome activity | |||
DCA/CA | 0.0459 | 8.01 [5.8–11.1] | 12 [7.89–18.1] |
TDCA/CA | 0.0056 | 0.469 [0.309–0.711] | 0.906 [0.517–1.59] |
GDCA/CA | 0.0007 | 5.76 [4.01–8.27] | 12.5 [7.71–20.2] |
LCA/CDCA | 0.451 | 0.66 [0.419–1.04] | 0.589 [0.42–0.825] |
UDCA/CDCA | 0.691 | 1.39 [0.815–2.36] | 1.94 [1.23–3.07] |
TUDCA | 0.0275 | 1.07 [0.78–1.48] | 1.92 [1.53–2.41] |